Combined heart-liver transplantation: Indications, outcomes and current experience

Eliza W Beal1, Khalid Mumtaz2, Don Hayes3

  • 1Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Insights

Combined heart-liver transplants are a rare but effective treatment for complex diseases. Outcomes are comparable to single organ transplants, with the liver potentially aiding graft tolerance.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Surgery

Background:

  • Combined heart-liver transplantation is a rare procedure for patients with combined fatal heart and liver diseases.
  • Indications include familial amyloidosis polyneuropathy and end-stage congenital heart disease.

Purpose of the Study:

  • To review the techniques and outcomes of combined heart-liver transplantation.
  • To assess the viability of this complex procedure.

Main Methods:

  • Review of 159 combined heart-liver transplantations performed in the US from 1988 to 2014.
  • Analysis of various surgical techniques including full cardiopulmonary bypass, venovenous bypass, and en-bloc or sequential transplantation.

Main Results:

  • Outcomes of combined heart-liver transplantation are comparable to isolated heart or liver transplants.
  • The liver graft may induce tolerance for other transplanted organs.

Conclusions:

  • Combined heart-liver transplantation is a viable option for select patients with complex conditions.
  • Further research into the immunomodulatory effects of liver grafts in combined transplantation is warranted.